FOXP3 and systemic lupus erythematosus: Findings in other studies, together with the Foxp3-polymorphism-associated genetic effect on the risk of SLE identified in this study, confirm our hypothesis that Foxp3 polymorphisms might be a proper candidate for use in autoimmune disease screening, including for SLE.